JSM 2017 Online Program

Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme

		Tweet
187	Mon, 7/31/2017, 12:30 PM - 1:50 PM		CC-Ballroom II
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Qi Jiang, Amgen Inc.
ML09:	Applying Bayesian Methodology to Precision Medicine — Judy X. Li, Regeneron Pharmaceuticals
ML10:	FDA Draft Guidance on Multiple Endpoints — Kate Liu, Amgen, Inc.
ML11:	How to Treat Site in Clinical Trials - Fixed or Random? — Chul Ahn, FDA
ML12:	How We Take Advantage of Big Data When Dealing with the Dilemma in Early-Phase Oncology? — Shaoyi Li, Celgene
ML13:	Non-Inferiority Trials for Efficacy and Safety — Steve Snapinn, Amgen